微尺度化学
细胞外小泡
化学
微尺度热泳
纳米技术
纳米尺度
流离失所(心理学)
粒子(生态学)
聚苯乙烯
微球
纳米粒子跟踪分析
生物标志物
生物系统
限制
乳腺癌
小泡
胞外囊泡
均方位移
纳米颗粒
人体乳房
生物医学工程
定量分析(化学)
质点位移
粒径
纳米
液体活检
聚合物
检出限
粒子聚集
细胞外
微泡
色谱法
微粒
癌症检测
作者
Xueer Huang,Ting Wu,Haixia Li,Jinyu Liu,Bihong Diao,Jiayi Xiao,Lihong Liu
标识
DOI:10.1021/acs.analchem.6c04739
摘要
Tumor-derived extracellular vesicles (EVs) are increasingly recognized as potential biomarkers for breast cancer (BC) diagnosis and molecular subtyping; however, most current analytical methods rely on laborious EV isolation and sophisticated instrumentation, limiting their routine clinical implementation. Herein, we report an aggregation-modulated deterministic lateral displacement (AM-DLD) platform for simple, label-free analysis of tumor-derived EVs without EV isolation. In this strategy, aptamer-functionalized polystyrene microspheres convert nanoscale EV recognition into microscale microsphere aggregates through target EV-mediated cross-linking, enabling direct analysis using a conventional DLD chip. Because EV-induced aggregation generates microsphere aggregates with heterogeneous sizes, a weighted lateral displacement index (LDI) was developed to integrate particle distributions across multiple DLD outlets into a single quantitative readout. Using EpCAM-positive EVs for BC detection and PD-L1-positive EVs for triple-negative BC (TNBC) classification, the AM-DLD platform achieved limits of detection of 8.20 × 105 and 1.67 × 106 particles mL-1, respectively, together with high linearity, specificity, stability, and recovery. Clinical validation using serum samples from 153 individuals yielded AUC values of 0.9806 for BC detection and 0.9642 for TNBC classification. This work establishes a generalizable signal-conversion strategy that extends conventional DLD technology from microscale particle manipulation to nanoscale biomarker analysis, providing an analytical platform for EV-based liquid biopsy.
科研通智能强力驱动
Strongly Powered by AbleSci AI